Cargando…
Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease
Autores principales: | Cechetto, Jonathan, Jeon, Hee Kyoung, Jang, Jiyeon, Kwon, Doyoon, Christophe, Thierry, Brodin, Priscille, Yang, Gyongseon, Neto, Jair, Freitas Junior, Lucio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019463/ http://dx.doi.org/10.1186/1753-6561-5-S1-P38 |
Ejemplares similares
-
An Image-Based High-Content Screening Assay for Compounds Targeting Intracellular Leishmania donovani Amastigotes in Human Macrophages
por: Siqueira-Neto, Jair L., et al.
Publicado: (2012) -
Phenomic technologies in drug discovery of neglected diseases
por: Nehrbass, Ulf
Publicado: (2011) -
Purinergic signalling: from discovery to current developments
por: Burnstock, Geoffrey
Publicado: (2014) -
Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New Scaffolds
por: Siqueira-Neto, Jair L., et al.
Publicado: (2010) -
Open drug discovery for the Zika virus
por: Ekins, Sean, et al.
Publicado: (2016)